The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies

scientific article

The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/MDS.26964
P698PubMed publication ID28370517

P50authorEduardo TolosaQ64754997
Rachel Saunders-PullmanQ64761222
Connie Fernández-Cid MarrasQ64857647
Kenneth MarekQ67209513
Roy N AlcalayQ67215512
P2093author name stringPiu Chan
John E Duda
Claustre Pont-Sunyer
Maurizio Facheris
Rubén Fernández-Santiago
Francisco Lomeña
Chelsea Caspell-Garcia
Christopher Coffey
Bjorg Waro
Elisabet Mondragon
LRRK2 Cohort Consortium
P2860cites workThe Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendationsQ28180426
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness ScaleQ28256570
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's diseaseQ28292932
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyQ29614953
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairmentQ29615678
What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic studyQ33220006
The Parkinson Progression Marker Initiative (PPMI).Q34217468
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's diseaseQ34361735
Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?Q34562789
The REM sleep behavior disorder screening questionnaire--a new diagnostic instrumentQ34692883
123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutationsQ35004642
Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriersQ35106295
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriersQ35119612
Olfactory dysfunction in LRRK2 G2019S mutation carriersQ35119617
Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participantsQ35219481
Clinical correlations with Lewy body pathology in LRRK2-related Parkinson diseaseQ35442728
Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation CarriersQ35692655
Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneQ35772821
Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 ConsortiumQ35850713
REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriersQ36470291
Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's diseaseQ37884907
Progress in defining the premotor phase of Parkinson's diseaseQ37890601
LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohortQ38900613
Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's diseaseQ39841718
Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriersQ42495787
Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain).Q42933007
Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2.Q43280089
Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonismQ44637181
Clinical features of LRRK2-associated Parkinson's disease in central NorwayQ44830290
Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutationsQ46521682
LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetranceQ46988538
Comparing the accuracy of different smell identification tests in Parkinson's disease: relevance of cultural aspectsQ47625425
DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease.Q47907932
Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson diseaseQ48206843
Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonismQ48248911
Subclinical signs in LRRK2 mutation carriersQ48299406
Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory functionQ52211663
Gait alterations in healthy carriers of the LRRK2 G2019S mutation.Q54616398
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.Q55041570
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)726-738
P577publication date2017-03-28
P1433published inMovement DisordersQ1486418
P1476titleThe prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies
P478volume32

Reverse relations

cites work (P2860)
Q60954941Advances in Parkinson's Disease: 200 Years Later
Q64864138An early diagnosis is not the same as a timely diagnosis of Parkinson's disease
Q51758052Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers
Q90569829Bringing radiomics into a multi-omics framework for a comprehensive genotype-phenotype characterization of oncological diseases
Q91069104Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Q54976661Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson's disease.
Q49886569Hypercholinergic activity in LRRK2 Parkinson's disease
Q54984575In Vitro Modeling of Leucine-Rich Repeat Kinase 2 (LRRK2) G2019S-Mediated Parkinson's Disease Pathology.
Q92933189LRRK2 in Parkinson disease: challenges of clinical trials
Q64759312Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders
Q64866924Olfactory Dysfunction in Neurodegenerative Diseases
Q93185922The prodromes of Parkinson's disease

Search more.